GSK-3β inhibitor 11
Modify Date: 2024-01-21 00:59:15
GSK-3β inhibitor 11 structure
|
Common Name | GSK-3β inhibitor 11 | ||
|---|---|---|---|---|
| CAS Number | 536731-65-4 | Molecular Weight | 393.416 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C20H15N3O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK-3β inhibitor 11GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM). GSK-3β inhibitor 11 can be used in neurodegenerative disease research[1]. |
| Name | 2H-Isoindole-2-acetamide, 1,3-dihydro-N-[4-(3-methoxyphenyl)-2-thiazolyl]-1,3-dioxo- |
|---|---|
| Synonym | More Synonyms |
| Description | GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM). GSK-3β inhibitor 11 can be used in neurodegenerative disease research[1]. |
|---|---|
| Related Catalog | |
| Target |
GSK-3β:10.02 μM (IC50) |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C20H15N3O4S |
| Molecular Weight | 393.416 |
| Exact Mass | 393.078339 |
| LogP | 3.76 |
| Index of Refraction | 1.686 |
| Storage condition | -20°C |
| 2H-Isoindole-2-acetamide, 1,3-dihydro-N-[4-(3-methoxyphenyl)-2-thiazolyl]-1,3-dioxo- |
| 2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]acetamide |